Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria

Overview of attention for article published in Cochrane database of systematic reviews, January 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter: 4 X users

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 94 Mendeley

Summary X Wikipedia Dimensions citations

So far, Dimensions has found 18 publications that cite this research output.

18

The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.

New guidelines reduce the risk of hospitalization for adult patients with uncomplicated Plasmodium falciparum malaria: An observational, multicenter, retrospective French study

Article in Infectious Diseases Now (August 2024)

Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis

Article in BMC Infectious Diseases (August 2024)

A randomized, open-label two-period crossover pilot study to evaluate the relative bioavailability in the fed state of atovaquone-proguanil (Atoguanil™) versus atovaquone-proguanil hydrochloride (Malarone®) in healthy adult participants

Article in Naunyn-Schmiedeberg's Archives of Pharmacology (June 2024)